Production (Stage)
Lisata Therapeutics, Inc.
LSTA
$2.69
$0.041.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.72M | -4.61M | -4.93M | -5.04M | -5.40M |
| Total Depreciation and Amortization | 43.00K | 41.00K | 42.00K | 45.00K | 46.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 489.00K | 556.00K | 266.00K | 104.00K | 402.00K |
| Change in Net Operating Assets | -1.21M | -515.00K | 2.10M | -388.00K | -2.07M |
| Cash from Operations | -5.40M | -4.53M | -2.52M | -5.28M | -7.03M |
| Capital Expenditure | -28.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.46M | 1.39M | -6.31M | 11.71M | 6.44M |
| Cash from Investing | 9.43M | 1.39M | -6.31M | 11.71M | 6.44M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 220.00K | 36.00K | 0.00 | 32.00K | -- |
| Repurchase of Common Stock | -243.00K | -132.00K | 0.00 | 0.00 | -142.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -23.00K | -96.00K | 0.00 | 32.00K | -142.00K |
| Foreign Exchange rate Adjustments | 2.00K | -65.00K | 39.00K | 26.00K | -55.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.01M | -3.30M | -8.78M | 6.49M | -788.00K |